National Guideline Clearinghouse | Certolizumab pegol for the treatment of rheumatoid arthritis.

National Institute for Health and Clinical Excellence (NICE)
Guideline Title
Certolizumab pegol for the treatment of rheumatoid arthritis.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Certolizumab pegol for the treatment of rheumatoid arthritis. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 Feb. 31 p. (Technology appraisal guidance; no. 186).

Guideline Status
This is the current release of the guideline.

full-text:
National Guideline Clearinghouse | Certolizumab pegol for the treatment of rheumatoid arthritis.